Viewing Study NCT02165332


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2025-12-31 @ 3:28 AM
Study NCT ID: NCT02165332
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2014-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module